Sun Pharma’s board will consider an NCD issue of up to ₹15,000 crore on October 12. The debentures are proposed to be issued through private placement in one or more tranches.
Sun Pharma’s board will consider an NCD issue of up to ₹15,000 crore on October 12. The debentures are proposed to be issued through private placement in one or more tranches.